Investment in colorectal cancer screening targeting pre-medicare population could cut Medicare treatment costs, study finds
Monday, October 18, 2010 - 11:20
in Health & Medicine
Investment in screening programs that target the pre-Medicare population, individuals aged between 50 and 64, could reduce the costs of colorectal cancer in the Medicare program, a new study finds. According to the findings, the up-front investment in screening individuals aged 50 to 64 was recouped only after they transition to Medicare at age 65.